Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $38.60 $44.37 Friday, 10th May 2024 XENE stock ended at $40.54. This is 4.59% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.26% from a day low at $38.60 to a day high of $42.56.
90 days $38.60 $50.99
52 weeks $27.99 $50.99

Historical Xenon Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jun 20, 2023 $40.49 $41.19 $40.15 $41.10 365 926
Jun 16, 2023 $42.31 $42.31 $40.56 $40.79 448 984
Jun 15, 2023 $42.54 $42.75 $40.98 $42.03 625 035
Jun 14, 2023 $43.06 $43.06 $41.90 $42.61 588 236
Jun 13, 2023 $42.51 $43.75 $42.00 $43.14 388 826
Jun 12, 2023 $42.36 $42.89 $41.45 $42.35 207 786
Jun 09, 2023 $42.43 $42.73 $41.93 $42.02 392 794
Jun 08, 2023 $41.57 $42.90 $41.34 $42.51 488 456
Jun 07, 2023 $40.03 $42.01 $39.45 $41.66 625 435
Jun 06, 2023 $39.25 $40.23 $39.21 $40.01 372 753
Jun 05, 2023 $38.84 $39.55 $38.63 $39.50 310 504
Jun 02, 2023 $38.74 $39.08 $38.09 $38.96 341 189
Jun 01, 2023 $38.44 $40.36 $38.14 $38.65 353 284
May 31, 2023 $38.49 $39.33 $38.14 $38.53 456 488
May 30, 2023 $40.26 $41.00 $38.29 $38.37 515 926
May 26, 2023 $40.30 $41.22 $40.00 $40.09 151 380
May 25, 2023 $41.46 $41.46 $40.09 $40.51 250 779
May 24, 2023 $41.53 $41.67 $40.63 $41.40 219 484
May 23, 2023 $42.09 $42.94 $41.67 $41.84 366 274
May 22, 2023 $41.14 $42.15 $40.56 $42.14 169 346
May 19, 2023 $41.17 $41.69 $40.94 $41.02 147 471
May 18, 2023 $41.15 $41.28 $40.21 $40.77 226 243
May 17, 2023 $41.12 $41.45 $40.25 $41.31 277 760
May 16, 2023 $41.67 $41.67 $40.65 $41.12 221 053
May 15, 2023 $40.40 $42.48 $40.40 $41.74 374 563
Click to get the best stock tips daily for free!

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o... XENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT